We’d be surprised if Integra LifeSciences Holdings Corporation (NASDAQ:IART) shareholders haven’t noticed that the , Lisa Evoli, recently sold US$150k worth of stock at US$63.00 per share. That sale was 47.9% of their holding, so it does make us raise an eyebrow.
The Last 12 Months Of Insider Transactions At Integra LifeSciences Holdings
In the last twelve months, the biggest single sale by an insider was when the COO & Corporate VP of International, Glenn Coleman, sold US$562k worth of shares at a price of US$63.00 per share. So we know that an insider sold shares at around the present share price of US$62.38. We generally don’t like to see insider selling, but the lower the sale price, the more it concerns us. In this case, the big sale took place at around the current price, so it’s not too bad (but it’s still not a positive).
Happily, we note that in the last year insiders paid US$308k for 5638 shares. But they sold 19198 for US$1.2m. All up, insiders sold more shares in Integra LifeSciences Holdings than they bought, over the last year. You can see the insider transactions (by individuals) over the last year depicted in the chart below. By clicking on the graph below, you can see the precise details of each insider transaction!
Insider Ownership of Integra LifeSciences Holdings
Many investors like to check how much of a company is owned by insiders. I reckon it’s a good sign if insiders own a significant number of shares in the company. It’s great to see that Integra LifeSciences Holdings insiders own 3.4% of the company, worth about US$184m. I like to see this level of insider ownership, because it increases the chances that management are thinking about the best interests of shareholders.
So What Does This Data Suggest About Integra LifeSciences Holdings Insiders?
Insiders sold Integra LifeSciences Holdings shares recently, but they didn’t buy any. Zooming out, the longer term picture doesn’t give us much comfort. But since Integra LifeSciences Holdings is profitable and growing, we’re not too worried by this. The company boasts high insider ownership, but we’re a little hesitant, given the history of share sales. Therefore, you should should definitely take a look at this FREE report showing analyst forecasts for Integra LifeSciences Holdings.
If you would prefer to check out another company — one with potentially superior financials — then do not miss this free list of interesting companies, that have HIGH return on equity and low debt.
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.
We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
If you spot an error that warrants correction, please contact the editor at firstname.lastname@example.org. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.